Suzhou Puhe

China

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Phase 3
Next date
None yet
 
Drugs
1
in active trials · 2 in all
Trials
1 active
3 since 2021

Drugs1

DrugHow it worksPartnerStageNext dateDetails
EGFR inhibitor
Phase 3 —

About

No active trial
PH009-1
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021

Follow Suzhou Puhe

Following is part of Solo: you see every change to Suzhou Puhe the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in